Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 3:24 pm Purchase |
2025-03-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Armistice Capital, LLC | 24,844,725 9.200% |
24,003,030 (+2851.75%) |
Filing History |
| 2025-03-04 10:32 am Purchase |
2025-02-26 | 13D | Cyclacel Pharmaceuticals, Inc. CYCC |
Doris Wong Sing Ee | 12,164,301 70.000% |
12,164,301 (New Position) |
Filing History |
| 2025-02-28 4:46 pm Purchase |
2025-02-06 | 13D | Cyclacel Pharmaceuticals, Inc. CYCC |
Lazar David E. | 2,438,824 15.840% |
2,438,824 (New Position) |
Filing History |
| 2025-02-14 5:40 pm Purchase |
2024-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Armistice Capital, LLC | 52,606 9.990% |
38,690 (+278.03%) |
Filing History |
| 2024-11-14 7:21 pm Sale |
2024-09-30 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Lind Global Fund II LP | 0 0.000% |
-6,391 (Position Closed) |
Filing History |
| 2024-11-14 3:27 pm Purchase |
2024-09-30 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Armistice Capital, LLC | 13,916 9.990% |
13,916 (New Position) |
Filing History |
| 2024-02-14 4:31 pm Sale |
2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Schonfeld Strategic Advisors LLC | 119 0.180% |
-3,091 (-96.30%) |
Filing History |
| 2024-02-14 10:09 am Sale |
2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Dellora Investments Master Fund LP | 0 0.000% |
-2,703 (Position Closed) |
Filing History |
| 2024-02-13 3:47 pm Unchanged |
2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Altium Capital Management LLC | 12,131 4.990% |
0 (Unchanged) |
Filing History |
| 2024-02-07 5:03 pm Sale |
2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
ACORN BIOVENTURES, L.P. | 0 0.000% |
-11,730 (Position Closed) |
Filing History |
| 2024-01-10 1:35 pm Purchase |
2023-12-21 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Altium Capital Management LLC | 12,131 8.000% |
12,131 (New Position) |
Filing History |
| 2024-01-04 4:30 pm Purchase |
2023-12-26 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Lind Global Fund II LP | 6,391 9.900% |
6,391 (New Position) |
Filing History |
| 2023-02-14 4:31 pm Purchase |
2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Schonfeld Strategic Advisors LLC | 3,210 6.140% |
3,210 (New Position) |
Filing History |
| 2023-02-13 4:16 pm Unchanged |
2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Dellora Investments Master Fund LP | 2,703 5.200% |
0 (Unchanged) |
Filing History |
| 2023-02-06 11:27 am Sale |
2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
SPHERA FUNDS MANAGEMENT LTD. | 1,042 1.990% |
-1,076 (-50.82%) |
Filing History |
| 2023-01-26 1:36 pm Purchase |
2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
ACORN BIOVENTURES, L.P. | 11,730 9.990% |
1,961 (+20.07%) |
Filing History |
| 2022-08-22 1:17 pm Purchase |
2022-08-11 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Dellora Investments Master Fund LP | 2,703 5.200% |
2,703 (New Position) |
Filing History |
| 2022-02-14 4:34 pm Sale |
2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Ikarian Capital, LLC | 414 1.000% |
-1,252 (-75.14%) |
Filing History |
| 2022-02-14 06:15 am Purchase |
2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
SPHERA FUNDS MANAGEMENT LTD. | 2,118 5.100% |
6 (+0.30%) |
Filing History |
| 2022-02-04 4:03 pm Unchanged |
2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Hudson Bay Capital Management LP | 1,719 3.970% |
0 (Unchanged) |
Filing History |